Abstract
The organometallic arene ruthenium complexes are rapidly advancing. In particular, the organoruthenium complexes of the type [(η6-arene)Ru(X)(Y)(Z)] have attracted increasing attention for their special structures and properties. This review is focused on the recent developments of [(η6- arene)Ru(X)(Y)(Z)]-typed complexes incorporating various biologically active ligands, which are important in the exploration of novel multi-targeted organometallic anticancer drugs.
Keywords: Anticancer agent, Arene, Biologically active ligands, Ruthenium.
Related Journals
Current Drug Research Reviews
Current Topics in Medicinal Chemistry
Medicinal Chemistry
CNS & Neurological Disorders - Drug Targets
Cardiovascular & Hematological Disorders-Drug Targets
Applied Drug Research, Clinical Trials and Regulatory Affairs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Anti-Infective Agents
Anti-Cancer Agents in Medicinal Chemistry
Combinatorial Chemistry & High Throughput Screening
Related Books
Frontiers in Bioactive Compounds
Frontiers in Bioactive Compounds
Frontiers in Bioactive Compounds
Frontiers in Medicinal Chemistry
Frontiers in Medicinal Chemistry
Frontiers in Medicinal Chemistry
Frontiers in Medicinal Chemistry
Frontiers in Medicinal Chemistry
Frontiers in Medicinal Chemistry
Frontiers in Medicinal Chemistry
72
7
1
1